Currently, Insmed Inc [INSM] is trading at $70.20, down -1.22%. Until recently, the best way to gauge how the stock has performed was to look at its short-term value. The INSM shares have gain 3.92% over the last week, with a monthly amount drifted -8.82%, and not seem to be holding up well over a long-time horizon.
From an analyst’s perspective:
Insmed Inc [NASDAQ: INSM] stock has seen the most recent analyst activity on February 25, 2025, when RBC Capital Mkts initiated its Outperform rating and assigned the stock a price target of $100. Previously, Truist started tracking the stock with Buy rating on April 23, 2024, and set its price target to $48. On February 15, 2024, Wolfe Research initiated with a Outperform rating and assigned a price target of $42 on the stock. Wells Fargo started tracking the stock assigning a Overweight rating and suggested a price target of $55 on December 08, 2023. Guggenheim started tracking with a Buy rating for this stock on July 26, 2023, and assigned it a price target of $50. In a note dated December 09, 2022, Mizuho initiated an Buy rating and provided a target price of $28 on this stock.
This stock has fluctuated between a low of $21.92 and a high of $84.91 over the last 52 weeks. Currently, Wall Street analysts expect the stock to reach $110 within the next 12 months. Insmed Inc [NASDAQ: INSM] shares were valued at $70.20 at the most recent close of the market. An investor can expect a potential return of 56.7% based on the average INSM price forecast.
Analyzing the INSM fundamentals
Trailing Twelve Months sales for Insmed Inc [NASDAQ:INSM] were 363.71M which represents 24.79% growth. Gross Profit Margin for this corporation currently stands at 0.76% with Operating Profit Margin at -2.2%, Pretax Profit Margin comes in at -2.5%, and Net Profit Margin reading is -2.51%. To continue investigating profitability, this company’s Return on Assets is posted at -0.45, Equity is -10.66 and Total Capital is -0.46. An extended analysis of the company’s primary financial structure reveals a debt-to-equity ratio of0.16.
Before buying any particular stock, readers tend to pay close attention to the indicators that support and create resistance. The company’s stock is currently sitting at 69.14 points at the first support level, and at 68.09 for the second support level. However, for the 1st resistance point, the stock is sitting at 71.11, and for the 2nd resistance point, it is at 72.03.
Ratios To Look Out For
To put it in perspective, the Current Ratio for Insmed Inc [NASDAQ:INSM] is 5.45. As well, the Quick Ratio is 5.12, while the Cash Ratio is 1.87. Considering the valuation of this stock, the price to sales ratio is 35.09, the price to book ratio is 44.13.
Transactions by insiders
Recent insider trading involved Lewis William, Chair and CEO, that happened on Apr 15 ’25 when 6830.0 shares were sold. Officer, Lewis William completed a deal on Apr 15 ’25 to buy 6830.0 shares. Meanwhile, Chair and CEO Lewis William sold 6830.0 shares on Apr 01 ’25.
